We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$14.3B
AUM Growth
-$123M
Cap. Flow
+$2.4M
Cap. Flow %
0.02%
Top 10 Hldgs %
18.7%
Holding
394
New
12
Increased
127
Reduced
181
Closed
15

Top Buys

Rank Stock Value
1
SYY icon
Sysco
SYY
+$39.5M
2
STE icon
Steris
STE
+$39.5M
3
GPK icon
Graphic Packaging
GPK
+$36.3M
4
UFPT icon
UFP Technologies
UFPT
+$31.4M
5
ORCL icon
Oracle
ORCL
+$29.1M

Top Sells

Rank Stock Value
1
SFM icon
Sprouts Farmers Market
SFM
+$92M
2
ATR icon
AptarGroup
ATR
+$52.8M
3
SBUX icon
Starbucks
SBUX
+$49.2M
4
IDCC icon
InterDigital
IDCC
+$38.8M
5
CORT icon
Corcept Therapeutics
CORT
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 23.92%
2 Financials 16.3%
3 Healthcare 14.03%
4 Industrials 13.35%
5 Consumer Discretionary 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
301
Salesforce
CRM
$151B
$687K ﹤0.01%
2,056
+17
+0.8% +$5.42K
VT icon
302
Vanguard Total World Stock ETF
VT
$77.1B
$658K ﹤0.01%
5,601
LHX icon
303
L3Harris
LHX
$51.6B
$658K ﹤0.01%
3,129
-166
-5% -$39.8K
QUAL icon
304
iShares MSCI USA Quality Factor ETF
QUAL
$46.4B
$639K ﹤0.01%
3,590
TRV icon
305
Travelers Companies
TRV
$78.1B
$623K ﹤0.01%
2,586
WAB icon
306
Wabtec
WAB
$49.1B
$607K ﹤0.01%
3,200
-41
-1% -$7.94K
GS icon
307
Goldman Sachs
GS
$300B
$604K ﹤0.01%
1,054
-13
-1% -$7.25K
CSX icon
308
CSX Corp
CSX
$93.4B
$603K ﹤0.01%
18,672
JEF icon
309
Jefferies Financial Group
JEF
$12.6B
$588K ﹤0.01%
7,500
MDLZ icon
310
Mondelez International
MDLZ
$79.5B
$581K ﹤0.01%
9,728
-270
-3% -$17.9K
SHW icon
311
Sherwin-Williams
SHW
$82.7B
$569K ﹤0.01%
1,674
-50
-3% -$18.7K
BA icon
312
Boeing
BA
$171B
$536K ﹤0.01%
3,027
-200
-6% -$31.4K
HCA icon
313
HCA Healthcare
HCA
$87.2B
$531K ﹤0.01%
1,768
NOW icon
314
ServiceNow
NOW
$115B
$524K ﹤0.01%
2,470
TT icon
315
Trane Technologies
TT
$100B
$515K ﹤0.01%
1,394
GEV icon
316
GE Vernova
GEV
$264B
$514K ﹤0.01%
1,564
+225
+17% +$70.3K
UL icon
317
Unilever
UL
$137B
$512K ﹤0.01%
8,027
+54
+0.7% +$3.65K
SCHW
318
Charles Schwab
SCHW
$183B
$493K ﹤0.01%
6,666
+120
+2% +$8.98K
VCIT icon
319
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$470K ﹤0.01%
5,860
-3,477
-37% -$284K
NVO
320
Novo Nordisk
NVO
$208B
$462K ﹤0.01%
5,366
CSL icon
321
Carlisle Companies
CSL
$14.3B
$443K ﹤0.01%
1,200
VEA icon
322
Vanguard FTSE Developed Markets ETF
VEA
$229B
$440K ﹤0.01%
9,207
+2,400
+35% +$121K
CAT icon
323
Caterpillar
CAT
$375B
$437K ﹤0.01%
1,204
-30
-2% -$11.6K
VEU icon
324
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$424K ﹤0.01%
7,391
-1,100
-13% -$66.3K
ALV icon
325
Autoliv
ALV
$9.02B
$415K ﹤0.01%
4,430

Similar funds

Boston Trust Walden's Q4 2024 Portfolio in Review

As of Q4 2024, Boston Trust Walden held 394 positions worth $14.3B, down 0.86% from $14.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q4 2024 filing shows 12 new, 127 increased, 181 reduced and 15 closed positions. Its largest new stake was Graphic Packaging: 1,256,679 shares worth $34.1M. The largest sale was Sprouts Farmers Market, an estimated $92M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q4 2024 buy was Graphic Packaging: 1,256,679 shares worth $34.1M.
  • Boston Trust Walden added most to Sysco in Q4 2024, an estimated $39.5M increase.
  • Boston Trust Walden's biggest Q4 2024 reduction was Sprouts Farmers Market, cutting an estimated $92M.
  • Boston Trust Walden fully exited Revvity in Q4 2024, selling an estimated $29.9M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $14.3B portfolio in Q4 2024.
  • Boston Trust Walden opened 12 new positions and closed 15 in Q4 2024.
  • Boston Trust Walden's portfolio value fell 0.86% quarter-over-quarter to $14.3B.

Based on Boston Trust Walden's 13F filing for Q4 2024, filed 24 Jan 2025.